Pharmaceutical composition used for treating metabolic syndrome disorders, infectious diseases, and complications thereof
OwnerGuy Faustin MONKAM NITCHEUinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition, characterized in that it comprises, as active ingredient, a combination of d-limonene, lupeol and a pharmaceutically active agent selected from cinnamaldehyde, epicatechin, methylhydroxychalcone polymer, beta-sitosterol, curcumin and mixtures thereof. It is suitable for use in the preventive and curative treatment of obesity, diabetes, dyslipidaemias, infections caused by infectious agents and the consequences thereof, and in invasive cancers, in particular those associated with adipose tissues.
Claims9
The pharmaceutical composition, which is characterized, it comprises in combination d-imoriene, lupeol and/or beta-sitosterol, cinnamaldehyde and/or methylhydroxychalcone polymer and as an option as curcumin, epicatechine.
Dependencies are inferred from the claim text.